null - FindTrial

N/A - ALLOZITHRO

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2013-000499-14-FR

Enrollment

Unknown

Registered

2015-09-25

Start date

2013-08-30

Completion date

Unknown

Last updated

2017-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 18.0 Level: LLT Classification code 10049202 Term: Bronchiolitis obliterans System Organ Class: 100000004855

Interventions

Trade Name: AZITHROMYCINE 250 mg Product Name: AZITHROMYCINE 250 mg Pharmaceutical Form: Tablet INN or Proposed INN: AZITHROMYCINE Concentration unit: mg milligram(s) Concentration type: equal Concent

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

France

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026